Formulation & Concentration
Antihemophilic Factor (Recombinant), PEGylated Lyophilized Powder for Solution

For Intravenous Injection

Manufacturer
Baxalta

Indications
ADYNOVATE, Antihemophilic Factor (Recombinant), PEGylated, is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older) with hemophilia A (congenital factor VIII deficiency) for the on-demand treatment and control of bleeding episodes and for routine prophylaxis to reduce the frequency of bleeding episodes.

ADYNOVATE is not indicated for the treatment of von Willebrand disease.

Vial Size NDC #
200 – 400 IU 00944-4252-02
401 – 800 IU 00944-4254-02
801 – 1250 IU 00944-4256-02
1251 – 2500 IU 00944-4258-02

Storage
Store Adynovate under refrigeration at a temperature of 36°F-46°F (2°C – 8°C). Adynovate may also be stored at room temperature not to exceed 86°F (30°C) for up to one (1)) month.